Celyad SA Analysis

Celyad Stock Analysis Notes

About 29.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.69. Some equities with similar Price to Book (P/B) outperform the market in the long run. Celyad SA recorded a loss per share of 1.47. The entity had not issued any dividends in recent years. Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T cell therapies for the treatment of cancer. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium. Celyad Sa operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people. For more info on Celyad SA please contact Christian Homsy at 32 1 039 41 00 or go to https://www.celyad.com.

Celyad SA Investment Alerts

Celyad SA Upcoming and Recent Events

Celyad Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 14.24 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Celyad SA's market, we take the total number of its shares issued and multiply it by Celyad SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Celyad SA prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Celyad shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Celyad SA. By using and applying Celyad Stock analysis, traders can create a robust methodology for identifying Celyad entry and exit points for their positions.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Celyad SA information on this page should be used as a complementary analysis to other Celyad SA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

If you are still planning to invest in Celyad SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Celyad SA's history and understand the potential risks before investing.